{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:58:00Z","timestamp":1791910680077,"version":"4.3.4"},"reference-count":178,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2019JDRC0091"],"award-info":[{"award-number":["2019JDRC0091"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673455"],"award-info":[{"award-number":["81673455"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803755"],"award-info":[{"award-number":["81803755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922064"],"award-info":[{"award-number":["81922064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.apsb.2021.02.016","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T13:13:30Z","timestamp":1614345210000},"page":"3015-3034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Kai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiou","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-9486","authenticated-orcid":false,"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.02.016_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2021.02.016_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2021.02.016_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2021.02.016_bib4","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/13543776.2012.728587","article-title":"Novel NMDA receptor modulators: an update","volume":"22","author":"Santangelo","year":"2012","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.apsb.2021.02.016_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/cn2000537","article-title":"Adenosine A2A receptor antagonists and Parkinson's disease","volume":"2","author":"Shook","year":"2011","journal-title":"ACS Chem Neurosci"},{"issue":"Suppl","key":"10.1016\/j.apsb.2021.02.016_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.13529","article-title":"Therapeutic approaches in Parkinson's disease and related disorders","volume":"139","author":"Valera","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2021.02.016_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.apsb.2021.02.016_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nature05925","article-title":"Ambra1 regulates autophagy and development of the nervous system","volume":"447","author":"Maria Fimia","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.02.016_bib9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.02.016_bib10","doi-asserted-by":"crossref","first-page":"14489","DOI":"10.1073\/pnas.0701311104","article-title":"Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration","volume":"104","author":"Komatsu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.02.016_bib11","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.2261-06.2006","article-title":"Induction of autophagy in axonal dystrophy and degeneration","volume":"26","author":"Wang","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1073\/pnas.1619876114","article-title":"Autophagy wins the 2016 Nobel Prizein Physiology or Medicine: breakthroughs in baker's yeast fuel advances in biomedical research","volume":"114","author":"Levine","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.02.016_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3858\/emm.2012.44.2.031","article-title":"Neuronal autophagy and neurodegenerative diseases","volume":"44","author":"Son","year":"2012","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.apsb.2021.02.016_bib14","doi-asserted-by":"crossref","first-page":"18062","DOI":"10.1074\/jbc.M116.764795","article-title":"Up-regulation of autophagy-related gene 5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinson's disease","volume":"292","author":"Hu","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update","volume":"31","author":"Nuytemans","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.apsb.2021.02.016_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fnins.2020.00577","article-title":"LRRK2 and \u03b1-synuclein: distinct or synergistic players in Parkinson's disease?.","volume":"14","author":"O\u2019Hara","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.01352","article-title":"Autophagy and LRRK2 in the aging brain","volume":"13","author":"Albanese","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3233\/JPD-202138","article-title":"LRRK2 and the endolysosomal system in Parkinson's disease","volume":"10","author":"Erb","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/jnc.14908","article-title":"Leucine-rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson disease","volume":"152","author":"Cogo","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2021.02.016_bib20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/cells9051115","article-title":"Alpha-synuclein and LRRK2 in synaptic autophagy: linking early dysfunction to late-stage pathology in Parkinson's disease","volume":"9","author":"Lamonaca","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2021.02.016_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-017-0426-8","article-title":"Age-dependent dopamine transporter dysfunction and serine129 phospho-\u03b1-synuclein overload in G2019S LRRK2 mice","volume":"5","author":"Longo","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.apsb.2021.02.016_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/cbf.3364","article-title":"LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase","volume":"36","author":"Ho","year":"2018","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.apsb.2021.02.016_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuron.2017.09.036","article-title":"Age-dependent dopaminergic neurodegeneration and impairment of the autophagy-lysosomal pathway in LRRK-deficient mice","volume":"96","author":"Giaime","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2021.02.016_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/15548627.2019.1603548","article-title":"LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10","volume":"16","author":"Wauters","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/15548627.2019.1603545","article-title":"Age-dependent accumulation of oligomeric SNCA\/\u03b1-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)","volume":"16","author":"Ho","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib26","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/hmg\/ddz004","article-title":"LRRK2 impairs PINK1\/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease","volume":"28","author":"Bonello","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2021.02.016_bib27","first-page":"1","article-title":"The role of alpha-synuclein and other Parkinson's genes in neurodevelopmental and neurodegenerative disorders","volume":"21","author":"Alejandra Morato Torres","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.02.016_bib28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/jnen\/63.12.1225","article-title":"Regional distribution of proteinase K-resistant \u03b1-synuclein correlates with Lewy body disease stage","volume":"63","author":"Neumann","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.apsb.2021.02.016_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.02.016_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.02.016_bib31","doi-asserted-by":"crossref","first-page":"14241","DOI":"10.1074\/jbc.RA119.008733","article-title":"Autophagy activation promotes clearance of \u03b1-synuclein inclusions in fibril-seeded human neural cells","volume":"294","author":"Gao","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/jnc.15174","article-title":"Distinct alpha-synuclein species induced by seeding are selectively cleared by the lysosome or the proteasome in neuronally differentiated SH-SY5Y cells","volume":"156","author":"Pantazopoulou","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2021.02.016_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-Synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2021.02.016_bib34","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s11064-020-03126-8","article-title":"\u03b1-Synuclein overexpression induces lysosomal dysfunction and autophagy impairment in human neuroblastoma SH-SY5Y","volume":"45","author":"Nascimento","year":"2020","journal-title":"Neurochem Res"},{"key":"10.1016\/j.apsb.2021.02.016_bib35","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"\u03b1-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.02.016_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-21325-w","article-title":"Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice","volume":"8","author":"Sato","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.02.016_bib37","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/hmg\/ddaa085","article-title":"Glucocerebrosidase deficiency promotes release of \u03b1-synuclein fibrils from cultured neurons","volume":"29","author":"Gegg","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2021.02.016_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15548627.2018.1509818","article-title":"Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations","volume":"15","author":"Li","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/ijms21051772","article-title":"PINK1\/Parkin mediated mitophagy, Ca2+ signalling, and ER-mitochondria contacts in Parkinson's disease","volume":"21","author":"Barazzuol","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.02.016_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JPD-160989","article-title":"PINK1, Parkin, and mitochondrial quality control: what can we learn about Parkinson's disease pathobiology?.","volume":"7","author":"Truban","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1083\/jcb.201804165","article-title":"ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome\u2013lysosome fusion","volume":"218","author":"Wang","year":"2019","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2021.02.016_bib42","doi-asserted-by":"crossref","first-page":"11803","DOI":"10.1038\/ncomms11803","article-title":"The Parkinson's disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway","volume":"7","author":"Bento","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.02.016_bib43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","article-title":"Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice","volume":"277","author":"Patil","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.apsb.2021.02.016_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000328516","article-title":"Resveratrol-activated AMPK\/SIRT1\/autophagy in cellular models of Parkinson's disease","volume":"19","author":"Wu","year":"2011","journal-title":"Neurosignals"},{"key":"10.1016\/j.apsb.2021.02.016_bib45","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1021\/acs.jmedchem.7b01575","article-title":"Small-molecule activator of UNC-51-like kinase 1 (ULK1) that induces cytoprotective autophagy for Parkinson's disease treatment","volume":"61","author":"Ouyang","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/417292a","article-title":"A common mechanism of action for three mood-stabilizing drugs","volume":"417","author":"Williams","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.02.016_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.pmch.2016.11.002","article-title":"Development of LRRK2 inhibitors for the treatment of Parkinson's disease","volume":"56","author":"Christensen","year":"2017","journal-title":"Prog Med Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nchembio.538","article-title":"Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2","volume":"7","author":"Deng","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2021.02.016_bib49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.expneurol.2017.07.019","article-title":"Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease","volume":"298","author":"West","year":"2017","journal-title":"Exp Neurol"},{"key":"10.1016\/j.apsb.2021.02.016_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4161\/auto.8.1.16645","article-title":"Beclin 1: a role in membrane dynamics and beyond","volume":"8","author":"Wirawan","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41418-018-0254-9","article-title":"Post-translational modifications of beclin-1 provide multiple strategies for autophagy regulation","volume":"26","author":"Hill","year":"2019","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2021.02.016_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.04.003","article-title":"The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse","volume":"68","author":"Savolainen","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/auto.8.1.18313","article-title":"Isorhynchophylline, a natural alkaloid, promotes the degradation of \u03b1-synuclein in neuronal cells via inducing autophagy","volume":"8","author":"Lu","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.fct.2018.12.027","article-title":"Corynoxine B ameliorates HMGB1-dependent autophagy dysfunction during manganese exposure in SH-SY5Y human neuroblastoma cells","volume":"124","author":"Yan","year":"2019","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.apsb.2021.02.016_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2017.01.063","article-title":"Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in\u00a0vitro model of Parkinson's disease","volume":"642","author":"Kang","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.apsb.2021.02.016_bib56","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1021\/acschemneuro.7b00247","article-title":"Gastrodin and isorhynchophylline synergistically inhibit MPP+-induced oxidative stress in SH-SY5Y cells by targeting ERK1\/2 and GSK-3\u03b2 pathways: involvement of Nrf2 nuclear translocation","volume":"9","author":"Li","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib57","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2021.02.016_bib58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-0-387-46401-5_8","article-title":"Neuroprotective effects of curcumin","volume":"595","author":"Cole","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.apsb.2021.02.016_bib59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/cn3001203","article-title":"Curcumin modulates \u03b1-synuclein aggregation and toxicity","volume":"4","author":"Singh","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib60","doi-asserted-by":"crossref","first-page":"236182","DOI":"10.1155\/2014\/236182","article-title":"CNB-001 a novel curcumin derivative, guards dopamine neurons in MPTP model of Parkinson's disease","volume":"2014","author":"Jayaraj","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.apsb.2021.02.016_bib61","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/15548627.2016.1179404","article-title":"A novel curcumin analog binds to and activates TFEB in\u00a0vitro and in\u00a0vivo independent of MTOR inhibition","volume":"12","author":"Song","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib62","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/ijms21041515","article-title":"A curcumin derivative activates TFEB and protects against parkinsonian neurotoxicity in\u00a0vitro","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.02.016_bib63","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/bph.14623","article-title":"Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease","volume":"176","author":"Khalifeh","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2021.02.016_bib64","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.apsb.2021.02.016_bib65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nbd.2015.06.008","article-title":"Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells","volume":"82","author":"Ambrosi","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2019.02.027","article-title":"Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers neuroprotection in SH-SY5Y cells and neurons exposed to MPP+-induced oxidative insult","volume":"135","author":"Zhong","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2021.02.016_bib67","doi-asserted-by":"crossref","first-page":"31380","DOI":"10.1038\/srep31380","article-title":"Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models","volume":"6","author":"Sanchez-Martinez","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.02.016_bib68","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A new glucocerebrosidase chaperone reduces \u03b1-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib69","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1021\/jm049334f","article-title":"Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor \u03b1","volume":"47","author":"Busch","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fnmol.2018.00109","article-title":"Modulation of autophagy by a small molecule inverse agonist of ERR\u03b1 is neuroprotective","volume":"11","author":"Suresh","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ebiom.2019.10.036","article-title":"Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration","volume":"50","author":"SN","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2021.02.016_bib72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/toxsci\/kfy155","article-title":"Role of c-Abl-GSK3\u03b2 signaling in MPP1-induced autophagy-lysosomal dysfunction","volume":"165","author":"Ren","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.02.016_bib73","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JPD-160867","article-title":"Nilotinib effects in Parkinson's disease and dementia with lewy bodies","volume":"6","author":"Pagan","year":"2016","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2019.01.023","article-title":"Multiple molecular pathways stimulating macroautophagy protect from alpha-synuclein-induced toxicity in human neurons","volume":"149","author":"H\u00f6llerhage","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.apsb.2021.02.016_bib75","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2006.05.005","article-title":"Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome","volume":"3","author":"Cool","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2021.02.016_bib76","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fnins.2018.00301","article-title":"Chronic caffeine treatment protects against \u03b1-synucleinopathy by reestablishing autophagy activity in the mouse striatum","volume":"12","author":"Luan","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib77","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in\u00a0vitro and in\u00a0vivo models of Parkinson's disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib78","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11481-014-9528-2","article-title":"Corynoxine, a natural autophagy enhancer, promotes the clearance of alpha-synuclein via Akt\/mTOR pathway","volume":"9","author":"Chen","year":"2014","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.apsb.2021.02.016_bib79","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1002\/jcb.26010","article-title":"Neuroprotective effects of loganin on MPTP-induced Parkinson's disease mice: neurochemistry, glial reaction and autophagy studies","volume":"118","author":"Xu","year":"2017","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.apsb.2021.02.016_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0220-x","article-title":"Modulating the catalytic activity of AMPK has neuroprotective effects against \u03b1-synuclein toxicity","volume":"12","author":"Bobela","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.apsb.2021.02.016_bib81","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JPD-171296","article-title":"Targeting AMPK signaling as a neuroprotective strategy in Parkinson's disease","volume":"8","author":"Curry","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.apsb.2021.02.016_bib83","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1038\/srep04874","article-title":"The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease","volume":"4","author":"Karuppagounder","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.02.016_bib84","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11011-014-9632-2","article-title":"A Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia","volume":"30","author":"Ashabi","year":"2015","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/JMN:17:1:45","article-title":"AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation","volume":"17","author":"Culmsee","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib86","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/STROKEAHA.107.490904","article-title":"Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke","volume":"38","author":"Li","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.apsb.2021.02.016_bib87","doi-asserted-by":"crossref","first-page":"104593","DOI":"10.1016\/j.phrs.2019.104593","article-title":"Emerging neuroprotective effect of metformin in Parkinson's disease: a molecular crosstalk","volume":"152","author":"Paudel","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2021.02.016_bib88","doi-asserted-by":"crossref","first-page":"114193","DOI":"10.1016\/j.bcp.2020.114193","article-title":"Activation of AMPK\/aPKC\u03b6\/CREB pathway by metformin is associated with upregulation of GDNF and dopamine","volume":"180","author":"Katila","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2021.02.016_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyw047","article-title":"Metformin prevents dopaminergic neuron death in MPTP\/P-induced mouse model of Parkinson's disease via autophagy and mitochondrial ROS clearance","volume":"19","author":"Lu","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.apsb.2021.02.016_bib90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnut.2016.00031","article-title":"Putative role of red wine polyphenols against brain pathology in Alzheimer's and Parkinson's disease","volume":"3","author":"Caruana","year":"2016","journal-title":"Front Nutr"},{"key":"10.1016\/j.apsb.2021.02.016_bib91","doi-asserted-by":"crossref","first-page":"21772","DOI":"10.1038\/srep21772","article-title":"Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition","volume":"6","author":"Park","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.02.016_bib92","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s12035-015-9124-3","article-title":"Resveratrol protects from toxin-induced Parkinsonism: plethora of proofs hitherto petty translational value","volume":"53","author":"ur Rasheed","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2021.02.016_bib93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/biof.1399","article-title":"Role of resveratrol in regulation of cellular defense systems against oxidative stress","volume":"44","author":"Truong","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.apsb.2021.02.016_bib94","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/mnfr.201600111","article-title":"Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of \u03b1-synuclein via SIRT1-deacetylated LC3","volume":"60","author":"Guo","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.apsb.2021.02.016_bib95","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1080\/10715762.2018.1489128","article-title":"Resveratrol provides neuroprotective effects through modulation of mitochondrial dynamics and ERK1\/2 regulated autophagy","volume":"52","author":"Lin","year":"2018","journal-title":"Free Radic Res"},{"key":"10.1016\/j.apsb.2021.02.016_bib96","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2174\/1381612825666190717110932","article-title":"The effect of resveratrol on neurodegenerative disorders: possible protective actions against autophagy, apoptosis, inflammation and oxidative stress","volume":"25","author":"Pourhanifeh","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.apsb.2021.02.016_bib97","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/ml400157g","article-title":"Discovery of pyridones as oral AMPK direct activators","volume":"4","author":"Mirguet","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.02.016_bib98","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2016.08.052","article-title":"Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings","volume":"124","author":"Zhou","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib99","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.celrep.2015.04.063","article-title":"Co-activation of AMPK and mTORC1 induces cytotoxicity in acute myeloid leukemia","volume":"11","author":"Sujobert","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2021.02.016_bib100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bov\u00e9","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib101","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2012.11.001","article-title":"MTOR: on target for novel therapeutic strategies in the nervous system","volume":"19","author":"Maiese","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.apsb.2021.02.016_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.12997\/jla.2020.9.1.8","article-title":"mTOR-coordinated post-transcriptional gene regulations: from fundamental to pathogenic insights","volume":"9","author":"Yeh","year":"2020","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.apsb.2021.02.016_bib103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11062-019-09798-5","article-title":"Neuroprotective effects of the small-molecule enhancer of rapamycin in the cellular model of Parkinson's disease","volume":"51","author":"Darabi","year":"2019","journal-title":"Neurophysiology"},{"key":"10.1016\/j.apsb.2021.02.016_bib104","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2021.02.016_bib105","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib106","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000332599","article-title":"Regulation of physiologic actions of LRRK2: focus on autophagy","volume":"10","author":"Ferree","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib107","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s12035-017-0496-4","article-title":"Neuroprotective effects of temsirolimus in animal models of Parkinson's disease","volume":"55","author":"Siracusa","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2021.02.016_bib108","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1570159X13666151030103027","article-title":"Targeting the autophagy\/lysosomal degradation pathway in Parkinsons disease","volume":"14","author":"Rivero-R\u00edos","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.apsb.2021.02.016_bib109","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/med.21535","article-title":"Mechanistic\/mammalian target of rapamycin: recent pathological aspects and inhibitors","volume":"39","author":"Abdel-Maksoud","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2021.02.016_bib110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cell.2006.03.035","article-title":"A pharmacological map of the PI3-K family defines a role for p110\u03b1 in insulin signaling","volume":"125","author":"Knight","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.02.016_bib111","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","article-title":"A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma","volume":"9","author":"Fan","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2021.02.016_bib112","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4161\/auto.23323","article-title":"The ULK1 complex sensing nutrient signals for autophagy activation","volume":"9","author":"Wong","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib113","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/ijms20030728","article-title":"Balancing mTOR signaling and autophagy in the treatment of Parkinson's disease","volume":"20","author":"Zhu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.02.016_bib114","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/15548627.2017.1422851","article-title":"ULK1 phosphorylates Ser30 of BECN1 in association with ATG14 to stimulate autophagy induction","volume":"14","author":"Park","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1083\/jcb.200504035","article-title":"Lithium induces autophagy by inhibiting inositol monophosphatase","volume":"170","author":"Sarkar","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2021.02.016_bib116","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(88)90287-7","article-title":"Alteration of inositol phospholipid metabolism in rat cortex by lithium but not carbamazepine","volume":"156","author":"Elphick","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2021.02.016_bib117","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bcp.12100","article-title":"The association between Parkinson's disease and anti-epilepsy drug carbamazepine: a case-control study using the UK General Practice Research Database","volume":"76","author":"Skow","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2021.02.016_bib118","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2020-322429","article-title":"Inflammatory bowel disease and Parkinson's disease: common pathophysiological links","volume":"70","author":"Lee","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.02.016_bib119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-10-20","article-title":"Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?.","volume":"10","author":"Rudenko","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.apsb.2021.02.016_bib120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-319-49969-7_5","article-title":"Lrrk2 and autophagy","volume":"14","author":"Manzoni","year":"2017","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.apsb.2021.02.016_bib121","doi-asserted-by":"crossref","first-page":"35106","DOI":"10.1038\/srep35106","article-title":"MTOR independent regulation of macroautophagy by leucine rich repeat kinase 2 via beclin-1","volume":"6","author":"Manzoni","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.02.016_bib122","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.neuron.2016.09.037","article-title":"A LRRK2-dependent endophilinA phosphoswitch is critical for macroautophagy at presynaptic terminals","volume":"92","author":"Soukup","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2021.02.016_bib123","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1093\/hmg\/ddp346","article-title":"LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model","volume":"18","author":"Alegre-Abarrategui","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2021.02.016_bib124","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/13543784.2020.1814252","article-title":"Therapeutic strategies for Parkinson's disease: promising agents in early clinical development","volume":"29","author":"Fabbri","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.apsb.2021.02.016_bib125","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.bmcl.2012.01.084","article-title":"Characterization of TAE684 as a potent LRRK2 kinase inhibitor","volume":"22","author":"Zhang","year":"2012","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.02.016_bib126","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ml300123a","article-title":"Brain penetrant LRRK2 inhibitor","volume":"3","author":"Choi","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.02.016_bib127","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1021\/jm300452p","article-title":"Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling","volume":"55","author":"Chen","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib128","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/jm401654j","article-title":"Discovery of highly potent, selective, and brain-penetrant aminopyrazole Leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors","volume":"57","author":"Estrada","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib129","doi-asserted-by":"crossref","first-page":"273ra15","DOI":"10.1126\/scitranslmed.aaa3634","article-title":"Effect of selective LRRK2 kinase inhibition on nonhuman primate lung","volume":"7","author":"Fuji","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2021.02.016_bib130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/jm5014055","article-title":"Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in\u00a0vivo active LRRK2 kinase inhibitor","volume":"58","author":"Henderson","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib131","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1021\/acs.jmedchem.7b00045","article-title":"Discovery of a 3-(4-pyrimidinyl) indazole (MLi-2), an orally available and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor that reduces brain kinase activity","volume":"60","author":"Scott","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib132","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav0820","article-title":"LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits","volume":"12","author":"Baptista","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2021.02.016_bib133","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tox.2018.01.003","article-title":"PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats","volume":"395","author":"Andersen","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.apsb.2021.02.016_bib134","doi-asserted-by":"crossref","first-page":"105049","DOI":"10.1016\/j.nbd.2020.105049","article-title":"LRRK2 kinase inhibitors reduce alpha-synuclein in human neuronal cell lines with the G2019S mutation","volume":"144","author":"Zhao","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cns.12660","article-title":"Effects of LRRK2 inhibitors on nigrostriatal dopaminergic neurotransmission","volume":"23","author":"Qin","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.apsb.2021.02.016_bib136","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncel.2018.00051","article-title":"LRRK2 contributes to secondary brain injury through a p38\/drosha signaling pathway after traumatic brain injury in rats","volume":"12","author":"Rui","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41531-017-0036-y","article-title":"Targeted kinase inhibition relieves slowness and tremor in a Drosophila model of LRRK2 Parkinson's disease","volume":"3","author":"Cording","year":"2017","journal-title":"Npj Park Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib138","doi-asserted-by":"crossref","first-page":"1800927","DOI":"10.1002\/advs.201800927","article-title":"3D cultures of Parkinson's disease-specific dopaminergic neurons for high content phenotyping and drug testing","volume":"6","author":"Bolognin","year":"2019","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2021.02.016_bib139","doi-asserted-by":"crossref","first-page":"e1368","DOI":"10.1038\/cddis.2014.320","article-title":"The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling","volume":"5","author":"Saez-Atienzar","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2021.02.016_bib141","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molcel.2017.01.027","article-title":"Phosphoglycerate kinase 1 phosphorylates beclin-1 to induce autophagy","volume":"65","author":"Qian","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2021.02.016_bib142","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin-1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in \u03b1-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2021.02.016_bib143","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1074\/jbc.M114.592931","article-title":"Prolyl oligopeptidase enhances \u03b1-synuclein dimerization via direct protein\u2212protein interaction","volume":"290","author":"Savolainen","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib144","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4161\/auto.26751","article-title":"HMGB1 is involved in autophagy inhibition caused by SNCA\/\u03b1-synuclein overexpression\u202f: a process modulated by the natural autophagy inducer corynoxine B","volume":"10","author":"Song","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib145","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s11064-018-2609-5","article-title":"Glycyrrhizic acid alleviates 6-hydroxydopamine and corticosterone-induced neurotoxicity in SH-SY5Y cells through modulating autophagy","volume":"43","author":"Yang","year":"2018","journal-title":"Neurochem Res"},{"key":"10.1016\/j.apsb.2021.02.016_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2004-4","article-title":"The crosstalk between autophagy and apoptosis was mediated by phosphorylation of Bcl-2 and beclin1 in benzene-induced hematotoxicity","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.02.016_bib147","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2021.02.016_bib148","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.02.016_bib149","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1038\/s41467-018-05862-6","article-title":"mTOR-dependent phosphorylation controls TFEB nuclear export","volume":"9","author":"Napolitano","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.02.016_bib150","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11481-012-9431-7","article-title":"Curcumin ameliorates the neurodegenerative pathology in A53T \u03b1-synuclein cell model of Parkinson's disease through the downregulation of mTOR\/p70S6K signaling and the recovery of macroautophagy","volume":"8","author":"Jiang","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.apsb.2021.02.016_bib151","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/iub.2209","article-title":"Neuroprotective effects of curcumin through autophagy modulation","volume":"72","author":"Forouzanfar","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.apsb.2021.02.016_bib152","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1111\/j.1582-4934.2009.00711.x","article-title":"Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin","volume":"13","author":"Liang","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.apsb.2021.02.016_bib153","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-0-387-46401-5_2","article-title":"Highly active anticancer curcumin analogues","volume":"595","author":"Mosley","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.apsb.2021.02.016_bib154","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/15548627.2018.1535292","article-title":"Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration","volume":"15","author":"Rusmini","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic gaucher's disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.apsb.2021.02.016_bib156","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s13311-014-0294-x","article-title":"A GCase chaperone improves motor function in a mouse model of synucleinopathy","volume":"11","author":"Richter","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.apsb.2021.02.016_bib157","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/cb600187q","article-title":"Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants","volume":"1","author":"Sawkar","year":"2006","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.apsb.2021.02.016_bib158","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","article-title":"Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled Trial","volume":"77","author":"Mullin","year":"2020","journal-title":"JAMA Neurol"},{"issue":"Suppl","key":"10.1016\/j.apsb.2021.02.016_bib159","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jnc.13517","article-title":"Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance","volume":"139","author":"Blanz","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2021.02.016_bib160","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","article-title":"The nuclear receptor superfamily: a structural perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Sci"},{"key":"10.1016\/j.apsb.2021.02.016_bib161","doi-asserted-by":"crossref","first-page":"101320","DOI":"10.11131\/2018\/101320","article-title":"The nuclear receptor field: a historical overview and future challenges","volume":"5","author":"Mazaira","year":"2018","journal-title":"Nucl Recept Res"},{"key":"10.1016\/j.apsb.2021.02.016_bib162","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/er.2008-0017","article-title":"Transcriptional control of energy homeostasis by the estrogen-related receptors","volume":"29","author":"Gigu\u00e8re","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2021.02.016_bib163","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/331091a0","article-title":"Identification of a new class of steroid hormone receptors","volume":"331","author":"Gigu\u00e8re","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.02.016_bib164","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/10799893.2010.487493","article-title":"The estrogen-related receptor alpha: the oldest, yet an energetic orphan with robust biological functions","volume":"30","author":"Ranhotra","year":"2010","journal-title":"J Recept Signal Transduct"},{"key":"10.1016\/j.apsb.2021.02.016_bib165","doi-asserted-by":"crossref","first-page":"35941","DOI":"10.1074\/jbc.M804543200","article-title":"Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components","volume":"283","author":"Yogalingam","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.02.016_bib166","first-page":"14","article-title":"C-Abl inhibition; A novel therapeutic target for Parkinson's disease","volume":"16","author":"Ibrahim Abushouk","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.apsb.2021.02.016_bib167","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40268-019-0266-z","article-title":"Multikinase Abl\/DDR\/Src inhibition produces optimal effects for tyrosine kinase inhibition in neurodegeneration","volume":"19","author":"Fowler","year":"2019","journal-title":"Drugs R D"},{"key":"10.1016\/j.apsb.2021.02.016_bib168","first-page":"3127","article-title":"The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210 (Bcr-Abl) tyrosine kinase and induces apoptosis of K562 leukemic cells","volume":"60","author":"Dorsey","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2021.02.016_bib169","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd839","article-title":"Glivec (ST1571, imatinib), a rationally developed, targeted anticancer drug","volume":"1","author":"Capdeville","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2021.02.016_bib170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2021.02.016_bib171","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2021.02.016_bib172","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","article-title":"C-Abl phosphorylates \u03b1-synuclein and regulates its degradation: implication for \u03b1-synuclein clearance and contribution to the pathogenesis of Parkinson's disease","volume":"23","author":"Mahul-Mellier","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2021.02.016_bib173","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.celrep.2019.09.029","article-title":"Impairment of macroautophagy in dopamine neurons has opposing effects on Parkinsonian pathology and behavior","volume":"29","author":"Hunn","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2021.02.016_bib174","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","article-title":"Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds","volume":"575","author":"Li","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.02.016_bib175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/15548627.2019.1688556","article-title":"ATTEC: a potential new approach to target proteinopathies","volume":"16","author":"Li","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib176","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/15548627.2020.1718362","article-title":"Targeting selective autophagy by AUTAC degraders","volume":"16","author":"Takahashi","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.02.016_bib177","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"AUTACs: cargo-specific degraders using selective autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2021.02.016_bib178","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","article-title":"Triggers, facilitators, and aggravators: redefining Parkinson's disease pathogenesis","volume":"42","author":"Johnson","year":"2019","journal-title":"Trends Neurosci"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:48:34Z","timestamp":1761929314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":178,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2211383521000642"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.02.016","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}